Rotational Thromboelastometry Helps to Reduce Blood Product Consumption in Critically Ill Patients during Small Surgical Procedures at the Intensive Care Unit - a Retrospective Clinical Analysis and Literature Search
Status PubMed-not-MEDLINE Language English Country Switzerland Media print-electronic
Document type Journal Article
PubMed
30574055
PubMed Central
PMC6288682
DOI
10.1159/000486453
PII: tmh-0045-0385
Knihovny.cz E-resources
- Keywords
- Fresh frozen plasma and platelet consumption, ROTEM, Rotational thromboelastometry, Small surgical interventions at ICU,
- Publication type
- Journal Article MeSH
BACKGROUND: Patients at intensive care units (ICUs) are often transfused to correct increased coagulation parameters (prothrombin time and activated partial thromboplastine time) and/or low platelet count. Thromboelastometry using whole blood is considered to be superior to these tests. In clinical praxis, prolonged standard tests are seen but thromboelastometry values are normal. The objective was to compare the blood product consumptions before and after the introduction of thromboelastometry assays into the treatment protocol during small surgical procedures at our mixed ICU. METHODS: We analyzed 1,879 patients treated at our ICU who underwent small interventions. We compared the fresh frozen plasma and platelet consumption before and after the introduction of rotational thromboelastometry into the routine use. The obtained data were compared to relevant research results from the PubMed database, the MeSH index in the Medline database, and Google Scholar using key words 'tromboelastometry', 'fresh frozen plasma' and 'platelets'. RESULTS: Annual fresh frozen plasma and platelet consumptions were significantly decreased following thromboelastometry introduction. The number of patients and procedures did not differ significantly during the periods analyzed. CONCLUSION: Routine thromboelastometry assays can enable significant reduction of blood product consumption in critically ill patients undergoing small surgery without any bleeding complications.
See more in PubMed
Walsh TS, Stanworth SJ, Prescott RJ, Lee RJ, Watson DM, et al. Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units. Crit Care Med. 2010;38:1939–1946. PubMed
Levi M, Opal SM. Coagulation abnormalities in critically ill patients. Crit Care. 2006;10:222. PubMed PMC
Heemskerk JW, Mattheij NJ, Cosemans JM. Platelet-based coagulation: different populations, different functions. J Thromb Haemost. 2013;11:2–16. PubMed
Gorlinger K, Saner FH. Prophylactic plasma and platelet transfusion in the critically ill patient: just useless and expensive or even harmful? BMC Anesthesiol. 2015;15:86. PubMed PMC
Müller MC, Arbous MS, Spoelstra-de Man AM, Vink R, Karakus A, et al. Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME) Transfusion. 2015;55:26–35. quiz 25. PubMed
Holland L, Sarode R. Should plasma be transfused prophylactically before invasive procedures? Curr Opin Hematol. 2006;13:447–451. PubMed
Saner FH. Rotational thrombelastometry: a step forward to safer patient care? Crit Care. 2014;18:706. PubMed PMC
Allen T. Thromboelastometry: its methodology, application, and benefits. MLO Med Lab Obs. 2014;46:26–29. PubMed
De Pietri L, Bianchini M, Montalti R, et al. Thrombelastography guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial. Hepatology. 2016;63:566–573. PubMed
Kim KN, Kim DW, Jeong MA. The usefulness of a classification and regression tree algorithm for detecting perioperative transfusion-related pulmonary complications. Transfusion. 2015;55:2582–2589. PubMed
Vymazal T, Horáček M, Duřpekt R, Hladíková M, Cvachovec K. Is allogeneic blood transfusion a risk factor for sternal dehiscence in cardiac surgery - a prospective observational study. Int Heart J. 2009;50:601–608. PubMed
Gajic O, Dzik WH, Toy P. Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm? Crit Care Med. 2006;34((5 suppl)):S170–173. PubMed
Lukas P, Durila M, Jonas J, Vymazal T. Evaluation of thromboelastometry in sepsis in correlation with bleeding during invasive procedures. Clin Appl Thromb Hemost. 2017 DOI: 10.1177/1076029617731624. PubMed PMC
Anderson L, Quasim I, Soutar R, Steven M, Macfie A, et al. An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med. 2006;16:31–39. PubMed
Görlinger K, Fries D, Dirkmann D, Weber CF, Hanke AA, et al. Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus Med Hemother. 2012;39:104–113. PubMed PMC
Schöchl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care. 2011;15:R83. PubMed PMC
Vymazal T. Massive hemorrhage management - a best evidence topic report. Ther Clin Risk Manag. 2015;11:1107–1111. PubMed PMC
Yang L, Stanworth S, Hopewell S, Doree C, Murphy M. Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion. 2012;52:1673–1686. PubMed
Whiting P, Al M, Westwood M, Ramos IC, Ryder S, Armstrong N, et al. Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2015;19:1–228. PubMed PMC